![]() | |
Clinical data | |
---|---|
Other names | U-6596; Ketofluoxymesterone; 11-Oxofluoxymesterone; 11-Ketofluoxymesterone; 9α-Fluoro-11-oxo-17α-methyltestosterone; 9α-Fluoro-17α-methylandrost-4-en-17β-ol-3,11-dione |
Routes of administration | By mouth |
Drug class | Androgen; Anabolic steroid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C20H27FO3 |
Molar mass | 334.431 g·mol−1 |
3D model ( JSmol) | |
| |
|
Oxofluoxymesterone (developmental code name U-6596), or ketofluoxymesterone, is an androgen and anabolic steroid (AAS) which was never marketed. [1] [2] [3] It was assessed in the treatment of breast cancer in women in the 1970s and showed effectiveness similar to that of other AAS. [1] [2] [4] The drug is the 11- dehydrogenated analogue and a metabolite of fluoxymesterone. [1] [2] [3] [5]
![]() | |
Clinical data | |
---|---|
Other names | U-6596; Ketofluoxymesterone; 11-Oxofluoxymesterone; 11-Ketofluoxymesterone; 9α-Fluoro-11-oxo-17α-methyltestosterone; 9α-Fluoro-17α-methylandrost-4-en-17β-ol-3,11-dione |
Routes of administration | By mouth |
Drug class | Androgen; Anabolic steroid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C20H27FO3 |
Molar mass | 334.431 g·mol−1 |
3D model ( JSmol) | |
| |
|
Oxofluoxymesterone (developmental code name U-6596), or ketofluoxymesterone, is an androgen and anabolic steroid (AAS) which was never marketed. [1] [2] [3] It was assessed in the treatment of breast cancer in women in the 1970s and showed effectiveness similar to that of other AAS. [1] [2] [4] The drug is the 11- dehydrogenated analogue and a metabolite of fluoxymesterone. [1] [2] [3] [5]